Medix Infusion provides infusion and injectable therapy to chronically and acutely ill patients in the home or at ambulatory infusion centers, prioritizing rural, suburban and other underserved markets. The company leverages proprietary technology and processes to drive operational efficiency, reduce cost of care, and support the industry’s shift toward value-based care. Medix operates a network of more than 30 locations across five states and runs home infusion pharmacy operations. Since its inception in April 2020 the company has reported 100% year-over-year growth and now impacts more than 4,600 patients. Management plans to use recent capital to support organic expansion and strategic acquisitions to broaden geographic reach and capacity. The company recently acquired infusion operations of the Center for Neurology and Spine to expand into Arizona and accelerate outpatient infusion access.

Total raised

$35M

Funding rounds

2

Latest round

Series B

Latest activity

Jan 2023